Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), announced today
that it has successfully completed the first commercial installation of
Visualize:Vascular(TM) in a key new market in the US. Visualize:Vascular(TM) has
been integrated into the standard protocols for carotid scanning of
VascuCare(TM), a premiere vascular ultrasound services provider in Northern
California, operating with full Intersocietal Accreditation Commission (IAC)
certification.


"Our vascular technologists and physician partners use state of the art
technologies to obtain consistent, reproducible results. We wanted to see the
benefit of Visualize:Vascular's 3D rendering in our vascular labs and we are
delighted with the results," commented Brad Hummel, CEO of VascuCare. "Visualize
is clinically relevant, easy to use and provides an additional source of
revenue. Our physicians find that the 3D is tremendously helpful in tough cases.
Our technologists just add a simple 10 second scan to their normal procedure and
the 3D report is available quickly and conveniently for the physicians to
review."


"VascuCare provides the services of superior technologists in the vascular labs
of many facilities including four hospitals and two outpatient clinics. Their
staff performs over 15,000 vascular ultrasound procedures per year," commented
Jeff Collins, CEO of Medipattern. "VascuCare is a strategic partner on the
further United States (US) rollout for Visualize:Vascular. Medipattern has been
targeting vascular ultrasound providers, such as in-facility providers and our
recently announced focus on mobile providers, which can facilitate penetrating
the US market as we intensify our adoption phase. Ultrasound providers, such as
VascuCare, use our products throughout their installed base with their end user
customers providing Medipattern more visibility and to roll out our products
more rapidly. California is a strategic target market for any company wishing to
establish itself on the west coast of the US. We appreciate the opportunity to
work with VascuCare in opening up the California market." 


About VascuCare:

VascuCare is operated by HDultrasound which was founded in 1999. VascuCare
provides high quality non-invasive vascular lab services throughout Northern
California including Alameda County Medical Center, Highland Hospital, Kaiser
Santa Clara, and Kaiser South San Francisco. For more information, please visit
www.vascucare.net.


About the Medipattern Corporation:

Medipattern(R) is an award-winning leader in the development and
commercialization of healthcare solutions that positively impact people's lives
through the prevention of disease and analysis of medical images and data.
Medipattern's Knowledge-based Informatics (MKI) platform enables delivery of
these streamlined solutions. Medipattern mHealth uses patented prevention
technologies to engage, coach and monitor people in achieving their personalized
goals. Medipattern iaHealth uses patented pattern recognition technology to
analyze medical data to aid medical practitioners in the assessment of disease
and critical anatomy. For more information, please visit the Company's website:
www.medipattern.com.


Medipattern(R) is registered trademarks of The Medipattern Corporation.
Visualize:Vascular(TM) is a registered trademark of Medipattern.


Forward-looking statements

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates," "believes," "estimates," "expects," "plans," "intends,"
"potential", and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). These factors should be
considered carefully, and readers should not place undue reliance on
Medipattern's forward-looking statements. In addition, these forward-looking
statements relate to the date on which they are made. The Company disclaims any
intention or obligation to update or revise any forward-looking statements for
any reason. Readers should not rely on forward-looking statements. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
The Medipattern Corporation
Jeff Collins
CEO
(416) 744-0009 ext. 224
jcollins@medipattern.com
www.medipattern.com


Spinnaker Capital Markets Inc.
Kevin O'Connor
(416) 962-3300 ext. 226
ko@spinnakercmi.com
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more The Medipattern Corp. Charts.
The Medipattern Corp. (TSXV:MKI)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more The Medipattern Corp. Charts.